A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer

Status unconfirmed · Phase 4

Conditions studied: Cancer

In brief

To obtain a preliminary characterization of the plasma PK and metabolites of actinomycin-D in children with cancer.

Key facts

Study ID

NCT00491946

Run by

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

People needed

24

Starts

2004-06-01

Last updated by the study team

2007-06-26

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 6 months - 18 years
• Due to receive actinomycin-D as a component of cancer treatment
• Central venous catheter (e.g. Port-a Cath, Broviac)
• Informed consent of parent or legal guardian and patient assent when appropriate

You may not qualify if…

• Serious illness other than the primary diagnosis of cancer
• Weight < 5 kilograms
• Previous participation in CHP-810

Where it is running

• Abramson Research Center — Philadelphia, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.